Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Q32 Bio Inc.
Report date March 25, 2024 · Filed April 23, 2024
Section 16 reporting ended · disclosed 2024-04-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,596 |
Reported balance
After 2024-03-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2024-03-25 · Sale · Disposed 268 · Balance 2,596 F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs. F2: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. |
Filing footnotes · ownership attribution and instrument terms
F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs.
F2: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 18,090 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 3 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 18,090 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 5,440 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · derivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,440 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. F2 · derivative.expiration_date: The vesting of these RSUs has been accelerated such that the RSUs vested in full on March 25, 2024, immediately prior to the Effective Time as defined in that certain Agreement and Plan of Merger by and among the Issuer, Kenobi Merger Sub, Inc. and Q32 Bio Inc. dated November 16, 2023. Read SEC document |
| March 25, 2024 Filed Mar 27, 2024 20:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 23,530 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-037197 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,566 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 25, 2024 Filed Apr 23, 2024 21:03 UTC | Q32 Bio Inc. QTTB · Entity 5594 | SaleCommon Stock | 268 | $24.21 | $6,488.28 |
DisclosureSEC source: 0000950170-24-047031 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,596 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of the RSUs. F2 · shares: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. F2 · balance_after: On March 25, 2024, the Issuer effected a 1-for-18 reverse stock split (the "Reverse Stock Split"). The share counts herein have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:54 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 7,280 | $0.57 | $4,120.48 |
DisclosureSEC source: 0000950170-24-002572 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,036 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units. F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $0.058 to $0.58. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 8,910 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 6 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,090 Underlying: Common Stock · 8,910 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 5,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 5 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,440 Underlying: Common Stock · 5,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 4,420 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · derivative · entry 4 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,420 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · derivative.exercise_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. F2 · derivative.expiration_date: The RSUs have vested and settled in full on January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 8,910 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 3 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,316 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 5,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,406 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2024 Filed Jan 3, 2024 21:15 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 4,420 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-000905 · ownership.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,126 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| March 02, 2023 Filed Mar 6, 2023 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 10,965 | $1.45 | $15,863.07 |
DisclosureSEC source: 0000899243-23-007174 · doc4.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,706 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2022. F2 · shares: This transaction reports the sale of 10,965 shares which were acquired on February 28, 2023 pursuant to the Issuer's Employee Stock Purchase Plan. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.37 to $1.52. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 3. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantRestricted Stock Units · Derivative | 27,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-006211 · doc4.xml · derivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,000 Underlying: Common Stock · 27,000 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. F3 · derivative.exercise_date: The restricted stock units will vest and settle as to one third of the restricted stock units on each of the first three anniversaries of January 1, 2023 so that such RSUs will become fully vested on January 1, 2026. F2 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | GrantEmployee Stock Option (Right to Buy) · Derivative | 164,000 | $0.00 Strike: $1.60 | $0.00 |
DisclosureSEC source: 0000899243-23-006211 · doc4.xml · derivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 164,000 Underlying: Common Stock · 164,000 shares Expires 2033-02-23 F1 · derivative.exercise_date: The option vests in 48 substantially equal monthly installments upon the Reporting Person's completion of each full month of service following January 1, 2023. Read SEC document |
| January 09, 2023 Filed Jan 11, 2023 21:05 UTC | Q32 Bio Inc. FIXX · Entity 5594 | SaleCommon Stock | 3,090 | $1.39 | $4,296.03 |
DisclosureSEC source: 0000899243-23-001577 · doc4.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,103 F1 · kind: The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the settlement of restricted stock units. F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $1.39 to $1.40. The Reporting Person undertakes to provide upon request the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote 2. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:32 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 5,280 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000624 · doc4.xml · derivative · entry 4 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,720 Underlying: Common Stock · 5,280 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F4 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. F4 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one third of the RSUs on each of the first three anniversaries of January 1, 2022 so that such RSUs will become fully vested on January 1, 2025. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:32 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionRestricted Stock Units · Derivative | 4,290 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-23-000624 · doc4.xml · derivative · entry 3 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,420 Underlying: Common Stock · 4,290 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F3 · derivative.exercise_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one half of the RSUs on each of January 1, 2023 and January 1, 2024. The RSUs do not have an expiration date. F3 · derivative.expiration_date: The RSUs have vested and settled or will vest and settle, as applicable, as to approximately one half of the RSUs on each of January 1, 2023 and January 1, 2024. The RSUs do not have an expiration date. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:32 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 5,280 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-000624 · doc4.xml · nonDerivative · entry 2 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,193 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 21:32 UTC | Q32 Bio Inc. FIXX · Entity 5594 | Exercise / conversionCommon Stock | 4,290 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-23-000624 · doc4.xml · nonDerivative · entry 1 Alloway Paul · CIK 0001916155 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of Issuer common stock. F2 · balance_after: Includes 3,397 shares acquired under Issuer's Employee Stock Purchase Plan on February 28, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.